As per the research of AstraZeneca (AstraZeneca is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England.)

As per the “AstraZeneca pharmaceuticals” People Who injected Covisheild during the covid – 19
Facing the rare chances of low platelets counts and formation of blood clots in “Very rare Cases”
AstraZeneca Found the connection of the syndrome of Thrombosis with Thrombocytopenia Syndrome (TTS) . This is the medical condition showcase the issues of Low level of platlets and formation of blood clots

What should we do while facing the symptoms of (TTS) ?

The symptoms of (TTS) is very rare according to AstraZeneca. But if an individual facing the problem the hospitlzation is must causing the formation blood clots and low platelets is not a good sign the advice of doctor and medical treatment is must plasma exchange may also be utilized for stabilizing the platletets level and manage immune system.

Supreme Court On the conterversy of covisheild vaccine.

The controversial News of covisheild vaccine reached the indian supreme court on Wednesday, May 1, 2024, with a petition seeking the constitution of an expert medical panel to study the risk factors.
The sudden death of people by cardiac arrest and collapse of person has been increased after covid-19. And after the result of AstraZeneca People is now getting threatened that is alls happening due to the connection of the syndrome of Thrombosis with Thrombocytopenia Syndrome (TTS) in covisheild vaccine which have been administered to the citizens at a large number,” the petition filed by advocate Vishal Tiwari said. The reason is more then 175cr of doses of covisheild used in india.

Mr. Tiwari further sought for the Vaccine Damage Payment System’ to the citizens who have facing the health issues after injecting covisheild or even deaths after taking the vaccine.